{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:06:42Z","timestamp":1789009602771,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cjco.2026.04.015","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:30:56Z","timestamp":1778023856000},"page":"1143-1150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-perceived Health Exceeds Societal Valuation Across Cardiac Neuromuscular Disease: Implications for Device Therapy Decision-making"],"prefix":"10.1016","volume":"8","author":[{"given":"Kathryn A.","family":"Albrecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina C.","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecily","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Dauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Coad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.H.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9556-1350","authenticated-orcid":false,"given":"Omid","family":"Kiamanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2026.04.015_bib1","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1161\/CIR.0000000000000526","article-title":"Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association","volume":"136","author":"Feingold","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2026.04.015_bib2","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.hrthm.2022.04.022","article-title":"2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders","volume":"19","author":"Groh","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2026.04.015_bib3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jacep.2017.04.023","article-title":"Neuromuscular disorders and the role of the clinical electrophysiologist","volume":"3","author":"Ismail","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjco.2026.04.015_bib4","first-page":"1","article-title":"The Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the selection, implantation, and management of patients with cardiac implantable electronic devices","volume":"42","author":"Andrade","year":"2026","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2026.04.015_bib5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1177\/0883073815627879","article-title":"Factors associated with health-related quality of life in children with Duchenne muscular dystrophy","volume":"31","author":"Wei","year":"2016","journal-title":"J Child Neurol"},{"key":"10.1016\/j.cjco.2026.04.015_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.0000000000000669","article-title":"The burden of Duchenne muscular dystrophy: an international, cross-sectional study","volume":"83","author":"Landfeldt","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.cjco.2026.04.015_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/mus.23245","article-title":"Quality of life and measures of quality of life in patients with neuromuscular disorders","volume":"46","author":"Burns","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cjco.2026.04.015_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030229","article-title":"Prognostic utility of cardiovascular magnetic resonance-based phenotyping in patients with muscular dystrophy","volume":"12","author":"Kashyap","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjco.2026.04.015_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014004","article-title":"Cardiac intervention improves heart disease and clinical outcomes in patients with muscular dystrophy in a multidisciplinary care setting","volume":"9","author":"Nikhanj","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjco.2026.04.015_bib10","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0277-9536(98)00411-0","article-title":"The disability paradox: high quality of life against all odds","volume":"48","author":"Albrecht","year":"1999","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.cjco.2026.04.015_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/21507740.2013.827273","article-title":"Stable value sets, psychological well-being, and the disability paradox: ramifications for assessing decision-making capacity","volume":"4","author":"Johnson","year":"2013","journal-title":"AJOB Neurosci"},{"key":"10.1016\/j.cjco.2026.04.015_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11136-024-03804-y","article-title":"Norms for the EQ-5D-5L among the general adult population in Alberta, Canada","volume":"34","author":"Al Sayah","year":"2025","journal-title":"Qual Life Res"},{"key":"10.1016\/j.cjco.2026.04.015_bib13","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/ejhf.3263","article-title":"Effect of dapagliflozin on health-related quality of life measured by EQ-5D-5L in patients with heart failure","volume":"26","author":"Yang","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2026.04.015_bib14","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1111\/ene.15854","article-title":"Determinants of quality of life in inherited and acquired myopathies","volume":"30","author":"Menon","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cjco.2026.04.015_bib15","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/mus.26022","article-title":"Cognitive impairment and quality of life in patients with myotonic dystrophy type 1","volume":"57","author":"Fujino","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cjco.2026.04.015_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12955-020-01663-y","article-title":"Response shift in health-related quality of life measures in the presence of formative indicators","volume":"19","author":"Testa","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.cjco.2026.04.015_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mus.23320","article-title":"Role of disease severity, illness perceptions, and mood on quality of life in muscle disease","volume":"46","author":"Rose","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cjco.2026.04.015_bib18","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2026.04.015_bib19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/dmcn.12959","article-title":"Quality of life in Duchenne muscular dystrophy: the disability paradox","volume":"58","author":"Pangalila","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.cjco.2026.04.015_bib20","first-page":"9","article-title":"To trach or not to trach, that is the question","volume":"29","author":"Macauley","year":"2018","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.cjco.2026.04.015_bib21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s11136-020-02722-z","article-title":"Discrepancies between proxy estimates and patient reported, health related, quality of life: minding the gap between patient and clinician perceptions in heart failure","volume":"30","author":"Prichard","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/j.cjco.2026.04.015_bib22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00005650-200411000-00014","article-title":"Self-valuation and societal valuations of health state differ with disease severity in chronic and disabling conditions","volume":"42","author":"McPherson","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.cjco.2026.04.015_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/hex.70431","article-title":"A Qualitative Examination of the Content Validity of the EQ-5D-5L and EQ-5D-Y-3L in Adult and Paediatric Patients With Duchenne Muscular Dystrophy","volume":"28","author":"Xu","year":"2025","journal-title":"Health Expect"},{"key":"10.1016\/j.cjco.2026.04.015_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12955-020-01511-z","article-title":"Measuring quality of life in Duchenne muscular dystrophy: a systematic review of the content and structural validity of commonly used instruments","volume":"18","author":"Powell","year":"2020","journal-title":"Health Quality Life Outcomes"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X26001666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X26001666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:20:59Z","timestamp":1789006859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X26001666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589790X26001666"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2026.04.015","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-perceived Health Exceeds Societal Valuation Across Cardiac Neuromuscular Disease: Implications for Device Therapy Decision-making","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2026.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}